Efficacy and Safety of Nitazoxanide in Addition to Standard of Care for the Treatment of Severe Acute Respiratory Illness

BACKGROUND: Effective therapeutics for respiratory viruses are needed. Early data suggest that nitazoxanide (NTZ) may be beneficial for treating acute respiratory viral illness. METHODS: From March 2014 through March 2017, a double-blind, placebo-controlled trial was conducted in 260 participants ≥1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Gamiño-Arroyo, Ana E, Guerrero, M Lourdes, McCarthy, Sean, Ramírez-Venegas, Alejandra, Llamosas-Gallardo, Beatriz, Galindo-Fraga, Arturo, Moreno-Espinosa, Sarbelio, Roldán-Aragón, Yuri, Araujo-Meléndez, Javier, Hunsberger, Sally, Ibarra-González, Violeta, Martínez-López, Julia, García-Andrade, Luis A, Kapushoc, Heather, Holley, H Preston, Smolskis, Mary C, Ruiz-Palacios, Guillermo M, Beigel, John H
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Articles and Commentaries
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6853643/
https://ncbi.nlm.nih.gov/pubmed/30753384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados